REG - Oxford BioDynamics - Holding(s) in Company

Oxford BiodynamicsAnnouncement

06/02/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250206:nRSF0918Wa&default-theme=true

RNS Number : 0918W  Oxford BioDynamics PLC  06 February 2025

TR-1: Standard form for notification of major holdings

 

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible) i

 

 1a. Identity of the issuer or the underlying issuer of existing shares to     OXFORD BIODYNAMICS PLC
 which voting rights are attached ii:
 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X"
 if appropriate)
 Non-UK issuer
 2. Reason for the notification (please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights                                                       X
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights
 Other (please specify) iii:

 

 3. Details of person subject to the notification obligation iv
 Name                                                   Arbuthnot Latham (Nominees) Limited
 City and country of registered office (if applicable)  London, United Kingdom
 4. Full name of shareholder(s) (if different from 3.) v
 Name
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reached vi:                             05/02/2025
 6. Date on which issuer notified (DD/MM/YYYY):                                        05/02/2025

 

 7. Total positions of person(s) subject to the notification obligation
                                                                            % of voting rights attached to shares (total of 8. A)  % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)  Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer (8.A + 8.B) vii
 Resulting situation on the date on which threshold was crossed or reached  3.79%                                                                                                                             3.79%                           74,250,303
 Position of previous notification (if applicable)                          9.13%                                                                                                                             9.13%

 

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reached viii
 A: Voting rights attached to shares
 Class/type of shares ISIN code (if possible)  Number of voting rights ix           % of voting rights
                                               Direct          Indirect (DTR5.2.1)  Direct      Indirect
                                               (DTR5.1)                             (DTR5.1)    (DTR5.2.1)
 GB00BD5H8572                                                  74,250,303                       3.79%

 SUBTOTAL 8. A                                 74,250,303                           3.79%

 

 B 1: Financial Instruments according to DTR5.3.1R (1) (a)
 Type of financial instrument  Expiration date x  Exercise/ Conversion Period xi  Number of voting rights that may be acquired if the instrument is  % of voting rights

exercised / converted.

 SUBTOTAL 8. B 1

 

 B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
 (1) (b)
 Type of financial instrument  Expiration date x  Exercise/ Conversion Pe-riod xi  Physical or cash  Number of voting rights  % of voting rights

                                                                                   Settlement xii

 SUBTOTAL 8.B.2

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the

 applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural                                                                                                                                     X
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuer xiii
 Full chain of controlled undertakings through which the voting rights and/or
 the financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entity (please add additional rows as
 necessary) xiv
 Name xv               % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                   than the notifiable threshold

 

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 

 11. Additional information xvi
 ·    Based on total voting rights of 1,957,577,641.

 ·    Oxford Biodynamics has recently successfully raised gross proceeds of
 £7 million in accordance to a placing, and therefore an additional
 1,400,000,000 new Ordinary Shares will be issued to the Placing and
 Subscriptions at the Issue Price. "therefore an additional 1,400,000,000 new
 Ordi-nary Shares will be issued to the Placing and Subscriptions at the Issue
 Price".

 ·   As this placing of shares has now settled, the report is being filed.

 

 Place of completion  London
 Date of completion   05/02/2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLEAFASEDXSEAA